BBC vs XBI

Virtus Biotech Clinical Trials ETF against State Street SPDR S&P Biotech ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
35%
75 shared positions
Fee gap
30 bp
XBI is cheaper
1-year return gap
6.5 pts
BBC is ahead
Larger fund
XBI
$9.9B

Side by side

BBCXBI
FundVirtus Biotech Clinical Trials ETFState Street SPDR S&P Biotech ETF
IssuerVirtusState Street SPDR
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.65%0.35%
Assets$42M$9.9B
Average daily dollar volume$866K$1.4B
ListedDec 16, 2014Jan 31, 2006
FrenzyCap score4496
1-month return−11.6%−1.9%
3-month return−14.0%−1.0%
Year to date+14.5%+26.1%
1-year return+52.3%+45.8%
30-day volatility32.2%27.0%
Worst drawdown, 1 year−22.8%−11.9%
Trailing 12-month yield1.49%0.35%
Holdings125166
Top 10 weight16.2%16.9%
Look-through P/E——
Holdings vs fair value+16.7%+5.8%
Holdings above 200-day average46%62%
Net flow, latest 3 reported months+$5.1M thru Jul 2026+$1.3B thru Jun 2026
30-day implied volatility43.3%31.2%
Holdings as ofas of Apr 30, 2026SEC filingas of Oct 8, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

62% of BBC · 39% of XBI
HoldingBBCXBI
SYRE1.64%1.39%
RVMD1.35%1.37%
ERAS2.19%1.33%
ORKA1.68%1.28%
KOD1.35%1.24%
DNTH1.54%1.17%
CGON1.21%1.00%
PCVX0.95%1.33%
TNGX1.71%0.94%
PRAX0.88%1.16%
RLAY1.19%0.87%
CELC0.85%0.83%
BEAM0.82%0.87%
PTGX0.77%1.46%
CYTK0.75%1.27%
SRRK0.73%0.79%
DYN0.67%0.73%
KYMR0.67%1.20%
IMVT0.76%0.66%
SMMT0.90%0.64%
COGT0.63%1.20%
VKTX0.62%0.98%
RXRX0.59%0.67%
IDYA0.63%0.59%
DNLI0.77%0.59%

Sector mix of the stock holdings

SectorBBCXBIGap
Health Care92.6%99.2%−6.6%
Financials0.0%0.7%−0.7%
Technology0.6%0.0%+0.6%

More: full overlap table · BBC holdings · XBI holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.